Trial
NCT01352611
Open Label Treatment of Severe Tactile Defensiveness With Intrathecal Baclofen
UnknownWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Missouri-Columbia
Collaborators
—
Condition
Autism Spectrum Disorder
Intervention
baclofen, intrathecal
Why stopped
No subjects enrolled.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-10-06